SPOPL pseudogene 2 (SPOPLP2)

SPOPL pseudogene 2 (SPOPLP2) is an uncharacterized pseudogene purportedly related to the SPECKLE TYPE BTB/POZ PROTEIN LIKE (SPOPL) gene, which encodes a protein involved in ubiquitin-mediated protein degradation and associated with pathologies such as Meier-Gorlin syndrome and prostate cancer[1]. Pseudogenes, including uncharacterized examples like SPOPLP2, generally do not encode functional proteins, but may play regulatory roles through sequence homology or non-coding RNA effects[3][4]. There is currently no evidence for any molecular function, therapeutic relevance, disease association, or drug interaction for SPOPL pseudogene 2. It is not considered a drug target and its existence may be primarily inferred from sequence annotation rather than biological evidence[1][3][4]. If you require information about SPOPL (the functional gene), substantial data is available regarding its role in protein degradation, disease mechanisms, and as a research target[1][2]. For “SPOPL pseudogene 2”, there appears to be no canonical functional or therapeutic information.